General Information of the Compound
Compound ID
CP0485861
Compound Name
2-[4-(2-Methoxy-phenyl)-piperidin-1-ylmethyl]-1H-benzoimidazole
    Show/Hide
Structure
Formula
C20H23N3O
Molecular Weight
321.424
Canonical SMILES
COc1ccccc1C1CCN(Cc2nc3ccccc3[nH]2)CC1
    Show/Hide
InChI
InChI=1S/C20H23N3O/c1-24-19-9-5-2-6-16(19)15-10-12-23(13-11-15)14-20-21-17-7-3-4-8-18(17)22-20/h2-9,15H,10-14H2,1H3,(H,21,22)
    Show/Hide
InChIKey
QKKFQHBDHBMWGM-UHFFFAOYSA-N
Physicochemical Property
logP
3.9511
Rotatable Bonds
4
Heavy Atom Count
24
Polar Areas
41.15
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10268039
SID: 15272843
ChEMBL ID
CHEMBL126361
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 100 nM
   TI
   LI
   LO
   TS